A team of UA scientists hope they have made progress toward a next-generation drug that may slow tumor growth and boost radiation’s effectiveness in patients with glioblastoma, a deadly brain cancer. The team includes BIO5 member Dr. Michael Hammer, Co-Director of the UA Cancer Center Genomics Shared Resource.
Related